Sarepta Therapeutics | SRPT - Eps Gewinn Pro Aktie

Aktienkurs
20.89
Täglich Wechseln
0.22 1.06%
Monatlich
-4.00%
Jährlich
-66.73%
Q2 Prognose
19.87

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 1.11 -3.42 May/06
FY2025Q4 Dec/2025 -3.58 -1.27 1.90 Feb/25
FY2025Q3 Sep/2025 -0.13 -0.6 0.62 Nov/03
FY2025Q2 Jun/2025 2.02 0.98 0.44 Aug/06
FY2025Q1 Mar/2025 -3.42 1.93 0.73 May/06




Eps Veränderung Datum
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Agios Pharmaceuticals USD -1.69 0.17 2026-03
Alnylam Pharmaceuticals USD 1.99 0.74 2026-03
Amgen USD 5.15 0.14 2026-03
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
Biogen USD 3.57 1.58 2026-03
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Capricor Therapeutics USD -0.62 0.08 2025-12
Daiichi Sankyo JPY 48.75 1.96 2026-03
Eli Lilly USD 8.55 1.01 2026-03
Esperion Therapeutics USD 0.26 0.42 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
Incyte USD 1.81 0.01 2026-03
Insmed USD -1.54 0.21 2025-12
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
Moderna USD -2.11 1.6 2025-12
Nektar Therapeutics USD -1.35 1.17 2025-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
Novavax USD 0.13 0.59 2025-12
Pfizer USD 0.66 0.21 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Regeneron Pharmaceuticals USD 9.47 1.97 2026-03
Roche Holding CHF 8.37 2.95 2025-12
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 1.88 0.35 2026-03
Sarepta Therapeutics USD -3.58 3.45 2025-12
Tectonic Therapeutic USD -1.03 0.01 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12